Dr. Giuseppe Giaccone, MD – New York, NY | Oncology
Dr. Giuseppe Giaccone | Mesothelioma Expert in New York
PPT - Tyrosine Kinase Inhibitors in non-small cell lung cancer PowerPoint Presentation - ID:3372145
Dr. Giuseppe Giaccone, MD, PhD | New York, NY | Oncologist
Dr. Giuseppe Giaccone, MD, PhD | New York, NY | Oncologist
Loop | Giuseppe Giaccone
Dr. Giaccone on Treatment Options in NSCLC | Giuseppe Giaccone, MD, PhD, of Weill Cornell Medicine discusses current treatment options in non–small cell lung cancer. https://bit.ly/32ELJ2F | By OncLive | Facebook
Atezolizumab bests chemo in NSCLC patients with high PD-L1 expression | MDedge Hematology and Oncology
Giuseppe Giaccone: Leading Clinical Oncology Research Expansion | Georgetown University Medical Center | Georgetown University
Loop | Giuseppe Giaccone
Dr. Giaccone on Treatment Options in NSCLC
Dr. Giaccone on Investigational Agents in Thymic Cancers
The Road to Progress in Lung Cancer Treatment - The ASCO Post
ITMIG 2017—Dr. Giuseppe Giaccone: focus on data and keep up-to-date - Huang - Mediastinum
Loop | Giuseppe Giaccone
Dr. Giuseppe Giaccone, MD – New York, NY | Oncology
Dr. Giaccone on Treatment Options in NSCLC
Giuseppe Giaccone, MD PhD, National Cancer Institute on Vimeo
Dr. Giuseppe Giaccone, MD: Hematologist - New York, NY - Medical News Today
ITMIG 2017# Interview with Dr. Giuseppe Giaccone: We should focus on data, and keep up-to-date - YouTube
Dr. Giaccone on Investigational Agents in Thymic Cancers
Loop | Giuseppe Giaccone
Loop | Giuseppe Giaccone
Loop | Giuseppe Giaccone
Giuseppe Giaccone, MD PhD, National Cancer Institute | Team Draft
